中文 English
Home
Patient Center
Clinical Trial
About Us
Chairman’s Message Our Company Leadership
Research&Development
Areas of Focus Pipeline
Newsroom
Company News Guidelines&Recomandations Publications
Contact Us
Contacts
Publications
Company News Guidelines&Recomandations Publications
Pharmacokinetics, Safety and Preliminary Efficacy of Multiple Doses of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW117) in Previously Treated Adult and Adolescent Subjects with Severe Hemophilia a: Results from an Open-Label
A Phase 1 Study to Evaluate the Pharmacokinetics and Safety of a PEGylated-Recombinant Human Coagulation Factor VIII-Fc Fusion Protein in Patients With Severe Hemophilia A
A Phase 1 Study to Evaluate the PK, Safety and Tolerability of a PEGylated-Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW117) with Extended Half-Life in Patients With Severe Hemophilia A
Pharmacokinetics, Efficacy and Safety Evaluation of FRSW107 in Previously Treated Hemophilia a Patients_ A Multicentre, Open-Label, Non-Randomized Phase III Study
Address
Jiangsu Gensciences：South of Xinxing Road, West of Guangxian Road, Nantong Economic Technolog Development Zone, Jiangsu
Beijing Gensciences：Building 18, Area B, BUT Software Park, 1 Disheng North Street, Daxing District, Beijing
Zhengzhou Gensciences：Building 20, Zhengzhou Linkong Biomedical Park, Zhengzhou Airport Economy District, Henan
Shanghai Gensciences：Building 5, Lane 111, Liangyao Road, Xinchang Township, Pudong New Area, Shanghai
Gensciences Xieyou：Building 5, Lane 111, Liangyao Road, Xinchang Township, Pudong New Area, Shanghai
Links
Home
Patient Center
About Us
Research&Development
Newsroom
Contact Us
WeChat Public Account

Scan to Add

Copyright: Jiangsu Gensciences Inc.     苏ICP备2022048559号-2    ghs苏公网安备32060002000102号